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The conservedmultifunctional protein Gle1 regulates
gene expression at multiple steps: nuclear mRNA
export, translation initiation, and translation termina-
tion. A GLE1 mutation (FinMajor) is causally linked to
human lethal congenital contracture syndrome-1
(LCCS1); however, the resulting perturbations on
Gle1 molecular function were unknown. FinMajor re-
sults in a proline-phenylalanine-glutamine peptide
insertion within the uncharacterized Gle1 coiled-coil
domain. Here, we find that Gle1 self-associates
both in vitro and in living cells via the coiled-coil
domain. Electron microscopy reveals that high-
molecular-mass Gle1 oligomers form 26 nm diam-
eter disk-shaped particles. With the Gle1-FinMajor
protein, these particles are malformed. Moreover,
functional assays document a specific requirement
for proper Gle1 oligomerization during mRNA export,
but not for Gle1’s roles in translation. These results
identify a mechanistic step in Gle1’s mRNA export
function at nuclear pore complexes and directly
implicate altered export in LCCS1disease pathology.
INTRODUCTION
Dysregulation of mRNA metabolism has emerged as a signifi-
cant factor in human disease pathologies, with proper control
of mRNA transcription, processing, nuclear export, translation,
and turnover being critical to cellular homeostasis, signaling,
division, and differentiation (Cooper et al., 2009; Hurt and Silver,
2008; Renoux and Todd, 2012). Gle1 is an essential multifunc-
tional protein, conserved from yeasts to humans, that plays a
direct role in both mRNA export and translation (Bolger et al.,
2008; Murphy and Wente, 1996; Watkins et al., 1998). Mutations
in the human (h) GLE1 gene are responsible for the autosomal
recessive lethal congenital contracture syndrome-1 (LCCS1)
disease (Nousiainen et al., 2008). LCCS1 is a severe in utero
form of a heterogeneous group of disorders, termed arthrogry-
posis multiplex congenita, that occur in 1 of 3,000 human births
worldwide (Hall, 1985). LCCS1 disease pathology is character-
ized by lack of anterior horn motor neurons and severe atrophy582 Cell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc.of ventral spinal cord, along with joint and jaw deformities (Herva
et al., 1985). Recent work indicates the pathological basis of this
disease is attributed to a reduction in Gle1 activity causing the
apoptosis of proliferative organ precursors during early develop-
ment (Jao et al., 2012). However, in LCCS1, the primary molec-
ular defects in hGle1 cellular roles are unknown.
Previous studies have revealedmultiple aspects of Gle1 struc-
ture and function in the budding yeast (y) Saccharomyces cere-
visiae and human cells (Figures 1A and 1B). The C-terminal
domains have extensive conservation, with 27% identical and
27% similar residues found between the regions by reported
sequence alignments (from residues 250–538 for yGle1 and
360–659 for hGle1; Watkins et al., 1998). Further, both have sig-
nificant spans in their N-terminal regions that are predicted to
form coiled-coil structures (Watkins et al., 1998). For mRNA
export, hGle1 docks at the nuclear pore complex (NPC) through
interactions with the NPC proteins hNup155 and hCG1 (yNup42
for yGle1; Kendirgi et al., 2005; Murphy andWente, 1996; Rayala
et al., 2004; Strahm et al., 1999; Stutz et al., 1997). hGle1 is also
dynamic, and its shuttling between the nucleoplasm and cyto-
plasm is essential for efficient mRNA export in human cells (Ken-
dirgi et al., 2003). Although humans have a single copy of the
hGLE1 gene, there are at least two alternatively spliced isoforms
(hGle1A and hGle1B; Kendirgi et al., 2003). Whereas hGle1B has
distinct steady-state localization at the NPC, the hGle1A isoform
lacks the C-terminal hCG1-binding domain and is predominantly
cytoplasmic. Thus, there are potentially distinct subcellular pools
of hGle1A and hGle1B that might reflect multiple roles in gene
expression.
During mRNA export and translation, yGle1 regulates the
RNA-dependent ATPase activities of specific DEAD-box pro-
teins (DBPs), thus controlling the action of these DBPs in nucle-
otide-dependent unwinding of RNA duplexes and/or remodeling
of the mRNA-particle (mRNP) protein composition (Alca´zar-
Roma´n et al., 2006; Bolger et al., 2008; Bolger and Wente,
2011;Weirich et al., 2006). Efficient yGle1 function at the NPC re-
quires inositol hexakisphosphate (IP6,) binding (Alca´zar-Roma´n
et al., 2010; York et al., 1999), and together, yGle1-IP6 triggers
Dbp5-dependent mRNP remodeling events required for direc-
tional export through NPCs (Tran et al., 2007). Conserved resi-
dues in both yGle1 and hGle1 are critical for IP6 binding and
Dbp5 activation (Figures 1A and 1B; Alca´zar-Roma´n et al.,
2010; Montpetit et al., 2011). In translation termination, yGle1-
IP6 directly interacts with Sup45 (eRF1) and is thought to activate
Figure 1. Conserved Structural and Func-
tional Elements of Gle1 from S. cerevisiae
and Humans
(A) Diagram depicting functional and structural
domains in S. cerevisiae (y)Gle1. Black arrow
represents the position of the y-gle1-4 mutation
(G382R; Watkins et al., 1998). White arrow marks
the location of conserved IP6-coordinating resi-
dues K377 and K378 (Alca´zar-Roma´n et al., 2010).
(B) Diagram depicting functional and structural
domains in human (h)Gle1B (adapted from Ken-
dirgi et al., 2005). ‘‘PFQ’’ denotes location of the
FinMajor insertion after amino acid 144 in the pre-
dicted coiled-coil domain (Nousiainen et al., 2008).
Black arrow represents the homologous position
(Q548) of the residue mutated in y-gle1-4 (Watkins
et al., 1998). White arrow marks the location of
conserved IP6-coordinating residues K526 and
K527 (Alca´zar-Roma´n et al., 2010).
(C) Paircoil2-generated structure predictions of
Gle1 polypeptide sequences, showing the struc-
tural effect of h-gle1-FinMajor and y-gle1-
engineered PFQ insertions. (+) indicates >50%
probability of coiled-coil structure. PFQ insertions
locations are designated by bold underlined
typeface. See Tables S1 and S2 for Paircoil2
scores and p values.Dbp5 for RNP remodeling to promote Sup35 (eRF3) association
(Bolger et al., 2008). During translation initiation, yGle1 and hGle1
interact with eIF3 proteins, and yGle1 is known to modulate a
different DBP, Ded1, for efficient start site recognition (Bolger
et al., 2008; Bolger and Wente, 2011). Thus, Gle1 serves as a
multifunctional effector of distinct steps in the gene expression
pathway.
The major LCCS1 causative mutation in hGLE1 is designated
FinMajor and is a single nucleotide substitution that alters a splice
site acceptor in the third intron (Nousiainen et al., 2008). This re-
sults in a three amino acid residue insertion (proline-phenylala-
nine-glutamine [PFQ]) in the N-terminal coiled-coil domain of
hGle1. LCCS1 patients are typically homozygous for the FinMajor
mutation, whereas heterozygotes show no reported phenotype
(Nousiainen et al., 2008). As noted above, the C-terminal domain
of hGle1 is linked to DBP regulation, nucleocytoplasmic shut-Cell 155, 582–593,tling, and IP6 binding (Alca´zar-Roma´n
et al., 2010; Kendirgi et al., 2003;Montpe-
tit et al., 2011; Weirich et al., 2006). The
N-terminal coiled-coil domain is also
essential in vivo (Watkins et al., 1998);
however, putative protein interaction
partners for the coiled-coil domain have
not been defined. It is also unclear
whether the coiled-coil domain is in-
volved in mRNA export and/or translation
or how it is functionally perturbed in
human LCCS1 disease.
Here, we investigated the function of
the coiled-coil domain and, in doing so,
defined the underlying mechanism forLCCS1 at the molecular level. We show that the coiled-coil
domain is critical for Gle1 self-association. Moreover, both
hGle1 oligomerization andmRNA export functions are perturbed
with the FinMajor protein. For yGle1, the coiled-coil domain is
specifically required for mRNA export and not translation. These
data reveal a step in the mRNA export pathway and provide
direct evidence for a defect in hGle1 regulation of mRNA export
at the NPC as the molecular mechanism causing the human
LCCS1 disease.
RESULTS
Gle1 Self-Associates In Vitro via Its Coiled-Coil Domain
To date, no protein interaction partners for the Gle1 coiled-coil
domain have been reported. Because coiled-coil domains are
often utilized to mediate homotypic interactions, we speculatedOctober 24, 2013 ª2013 Elsevier Inc. 583
that Gle1 might self-associate. To test this, a series of in vitro
biochemical experiments were conducted with recombinant
purified proteins. First, for in vitro soluble binding assays, a gluta-
thione S-transferase (GST)-tagged N-terminal region of hGle1
(residues 1–362; GST-hGle1(1–362)) was expressed and purified
from bacteria. GST-hGle1(1–362) or GST alone was incubated
with [35S]methionine-labeled hGle1(1–362) generated with an
in vitro rabbit reticulocyte lysate system and glutathione-Sephar-
ose beads. Bound [35S]-hGle1(1–362) was eluted and analyzed
by SDS-PAGE and autoradiography. An increased level of
[35S]-hGle1(1–362) was bound with GST-hGle1(1–362) as
compared to GST alone (Figure S1A available online). This
suggested that the coiled-coil domain is sufficient to mediate
self-association.
As an independent assessment of Gle1 self-association, sedi-
mentation velocity analytical ultracentrifugation (SVAU) was
employed. For this, recombinant maltose-binding protein
(MBP)-hGle1(1–362) was purified from bacteria (Figure S1B).
MBP-hGle1(1–362) protomer itself has a predicted molecular
mass of 0.084 MDa. Strikingly, MBP-hGle1(1–362) sedimented
in a series of distinct peaks corresponding to at least eight spe-
cies with high relativemolecular masses ranging from 0.096MDa
to 2.0 MDa (Figure S2A). As controls, we examined purified MBP
alone and a purified recombinant yGle1 polypeptide for the
C-terminal domain (residues 241–538; yGle1(241–538)) by
SVAU. For both, a single peak of low molecular mass was
observed at 0.044 and 0.040 MDa, respectively (Figures S2C
and S2D). Overall, the N-terminal coiled-coil domain of hGle1
was both necessary and sufficient to form large in vitro com-
plexes potentially representing higher-order oligomers. Next,
the oligomeric state of recombinant MBP-h-gle1(1–365)-FinMajor
was analyzed by SVAU. Similar to wild-type, MBP-h-gle1(1–
365)-FinMajor sedimented in a series of distinct peaks ranging
from 0.097 MDa to 1.9 MDa (Figure S2B). Thus, the FinMajor pro-
tein also self-associated and formed oligomeric complexes.
hGle1 Oligomers Form Disk Structures that Are
Disorganized with FinMajor
To gain insight into the hGle1 oligomer structure, the high-molec-
ular-mass MBP-hGle1(1–362) complexes were analyzed using
negative stain electron microscopy (EM). Purified, recombinant
MBP-hGle1(1–362) samples at0.5mg/ml were further fraction-
ated by size exclusion chromatography. Negative stain EM
revealed that MBP-hGle1(1–362) formed ring/disk structures,
as shown in a representative field (Figure 2A) and the montage
of individual ring/disks (Figure 2B). Measurements of the diam-
eter for 500 particles ranged from 15 nm to 60 nm, with an
average size of 25.8 nm (SD of 6.64 nm; Figure 2F). To further
investigate the structures, cryo-electron microscopy (cryo-EM)
was conducted, allowing preservation of native protein structure
and eliminating negative staining artifacts. The cryo-EM images
showed that MBP-hGle1(1–362) oligomers adopted a disk-like
shape in solution (Figure 2G).
We next examined recombinant MBP-h-gle1(1–365)-FinMajor
protein by negative stain EM. MBP-h-gle1(1–365)-FinMajor also
formed disk-shaped particles; however, these appeared struc-
turally disorganized compared to wild-type disks (Figures 2C
and 2D). Fields of particles from independent purifications584 Cell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc.were compared and individual particles binned into three distinct
structural categories: (1) aggregates; (2) disordered disks; and
(3) round disks (Figure 2E). A significantly greater proportion of
the MBP-h-gle1(1–365)-FinMajor particle samples were disor-
dered disks. We concluded that the PFQ insertion perturbs the
in vitro oligomeric complex.
Gle1 Oligomerization Is Structurally Conserved
We hypothesized that recombinant yGle1 would also form disk-
like oligomeric structures. To investigate this, recombinant, un-
tagged, full-length yGle1 was purified and further fractionated
by size exclusion chromatography. By negative stain EM, similar
toMBP-hGle1(1–362), yGle1 formed disk-like structures (Figures
2H and 2I). Importantly, as isolation of untagged full-length hGle1
was technically not possible, analysis of full-length, untagged
yGle1 provided strong evidence that disk structure formation
was intrinsic to Gle1 and not an artifact of either the MBP tag
or an isolated N-terminal domain. Moreover, the structural
characteristics of the oligomer were conserved between yGle1
and hGle1.
hGle1 Self-Associates in Living Cells
To test whether hGle1 self-associates in human cells, Forster
resonance energy transfer (FRET) microscopy was used. Plas-
mids expressing hGle1B tagged with mVenus (Venus) or
mCerulean3 (Cer3) were cotransfected into HeLa cells. FRET
measurements were made in living cells 12 hr posttransfection
using photoacceptor bleaching FRET microscopy (Figure 3A).
Strikingly, a FRET interaction of Cer3-hGle1B and Venus-hGle1B
wasdetected in the cytoplasm (9.19%FRETefficiency) and in the
nucleoplasm (5.85% FRET efficiency). In comparison, the per-
cent FRET efficiency between Cer3 alone and Venus-hGle1B
was low (<1.25%) in both the cytoplasm and nucleoplasm. As
an additional control, a Venus fusion protein for only the hGle1B
C-terminal region (residues 362–698) was tested. Only low
FRET efficiency (<2.0%) for both the nucleoplasmand cytoplasm
was detected with coexpression of Cer3-hGle1B and Venus-
hGle1B(362–698) (Figure 3A). Thus, the coiled-coil domain was
required to mediate hGle1B self-association in living cells.
During the acceptor-bleaching event (50 s), subtle move-
ment of the nuclear rim prevented accurate FRETmeasurements
using the photoacceptor bleaching method. Thus, sensitized
emission FRET measurements were made. In cells expressing
Cer3-hGle1B and Venus-hGle1B, we observed a normalized
FRET (NFRET) signal in the cytoplasm (12.9), nucleoplasm
(6.22), and at the nuclear rim (12.8; Figure 3B). In cells expressing
Cer3 and Venus-hGle1B cells, low NFRET (<4.08) signal was
detected in all respective locations (Figure 3B). Together, these
results indicated that hGle1 has the capacity to self-associate,
at a minimum, as a dimer pair in living cells.
FinMajor Perturbs Essential hGle1 Function in mRNA
Export
To investigate whether the FinMajor phenotype is due to per-
turbed mRNA export, translation initiation, and/or translation
termination, several independent tests were conducted. Our
previous studies found that hGle1 localization at the NPC is
dependent on interactions with both hNup155 and hCG1
Figure 2. Gle1 Oligomers Form Disk Structures
(A and B) hGle1 forms large circular structures. (A) Representative EM image
for purified MBP-hGle1(1–362). The scale bar represents 50 nm. (B) Gallery of
individual MBP-hGle1(1–362) particles. The scale bar represents 25 nm.
(C–E) FinMajor particles are malformed and disorganized. (C) Representative
EM image of MBP-h-gle1(1–365)-FinMajor. The scale bar represents 50 nm.
(D) Gallery of individual MBP-h-gle1(1–365)-FinMajor particles. The scale bar
represents 25 nm. (E) Quantification of particle morphology for MBP-hGle1(1–
362) and MBP-h-gle1(1–365)-FinMajor samples, categorized as aggregates,
disorganized, or round.
(F) hGle1 particles vary in diameter. Histogram of the measured diameter of
MBP-hGle1(1–362) particles.
(G) hGle1 oligomeric particles form disk-like structures. Cryo-EM images of
MBP-hGle1(1–362) disk-shaped structures in vitrified ice. The scale bar rep-
resents 25 nm.
(H and I) Oligomeric disk structures are conserved through evolution. (H)
Representative EM image of recombinant yGle1. The scale bar represents
50 nm. (I) Gallery of individual yGle1 particles. The scale bar represents 25 nm.
See also Figures S1 and S2.(Kendirgi et al., 2005; Rayala et al., 2004) and that hGle1 interacts
with the translation initiation factor eIF3f (Bolger et al., 2008).
Using the yeast two-hybrid assay, GBD-hGle1B and GBD-FinMajor
DNA-binding domain (BD) bait proteins were analyzed with
respective activation domain (AD) GAD-hCG1, GAD-hNup155,
or GAD-eIF3f prey proteins, with b-galactosidase expression as
the interaction readout. In all cases, the GBD-FinMajor was similar
to wild-type GBD-hGle1B (Figure S3A). This suggested that the
FinMajor protein was properly folded. Furthermore, the hCG1,
Nup155, and eIF3f interactions were not perturbed by the PFQ
insertion (Figure S3A).
Because the LCCS1 disease is a homozygous recessive con-
dition, we established a siRNA knockdown and add-back
human cell culture model system. As confirmed by immunoblot-
ting, endogenous hGle1 levels were reduced by transfection of
a small interfering RNA (siRNA) targeting hGLE1 (Figure 4A,
lane 2). As a control, a scrambled siRNA was tested in parallel
(CTRL). To assay mRNA export, the cellular distribution of bulk
poly(A)+RNA in hGLE1 and CTRL siRNA cells was monitored
by in situ hybridization with an oligo (dT) probe. Only cells treated
with the hGLE1 siRNA showed robust nuclear accumulation of
poly(A)+RNA (Figure 4B).
Rescue of the mRNA export defect was analyzed by express-
ing eitherGFP alone, a GFP-tagged siRNA-resistant (R) hGLE1B
gene (GFP-hGLE1BR), or a GFP-tagged siRNA-resistant FinMajor
gene (GFP-FinMajor
R). For each trial, the nuclear/cytoplasmic
(N/C) ratio of the poly(A)+RNA distribution was determined by
measuring fluorescence intensity. For CTRL siRNA with expres-
sion of GFP, GFP-hGLE1BR, or GFP-FinMajor
R, the mean N/C
ratio was 1.2, with no significant difference between the three
conditions. In contrast, the mean N/C ratio for expression of
only GFP with the hGLE1 siRNA was 1.6, reflecting nuclear
accumulation. Importantly, expression of GFP-hGLE1BR with
the hGLE1 siRNA rescued the mRNA export defect (mean N/C
ratio = 1.2) confirming that the hGLE1 siRNA phenotype was
not due to off-target effects (Figures 4B and S3B). However,
most strikingly, expression of the GFP-FinMajor
R did not rescue
the hGLE1 siRNA poly(A)+RNA nuclear accumulation defect
(mean N/C ratio = 1.5). Immunoblotting confirmed expression
of the GFP-hGle1BR (Figure 4A, lane 4) and GFP-FinMajor
RCell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc. 585
Figure 3. hGle1B Self-Associates in Living Cells
(A) hGle1B self-associates in living cells. Analysis of hGle1B interactions by
acceptor photobleaching FRET microscopy in HeLa cells expressing the
indicated fluorescent protein FRET pairs. FRET efficiencies of indicated re-
gionsweremeasured. Nucleoplasm and cytoplasm are designated by ‘‘N’’ and
‘‘C,’’ respectively. Error bars represent mean ± 95% confidence interval (CI)
with nR 20 cells from two independent experiments.
(B) hGle1B self-associates at the nuclear rim. Analysis of sensitized emission
FRET at the nuclear rim in HeLa cells expressing the indicated proteins. Shown
are representative images of Venus-hGle1B (acceptor), Cer-hGle1B (donor),
and the NFRET intensity map signal (top). The scale bar represents 10 mm. Bar
graph depicts the NFRET signal for indicated regions (bottom). Nucleoplasm,
cytoplasm, and nuclear rim are abbreviated as ‘‘N,’’‘‘C,’’ and ‘‘NR,’’ respec-
tively. Error bars for each condition represent mean ± 95%CI with nR 15 cells
from at least two independent experiments.
See also Figure S3.(Figure 4A, lane 6) proteins. Moreover, similar to GFP-hGle1BR,
the GFP-FinMajor
R localized to the nuclear rim in both the CTRL
and hGLE1 siRNA cells (Figure 6B). Thus, we concluded that
FinMajor is defective for function in mRNA export.
FinMajor Mimic Insertions in yGle1 Specifically Alter
mRNA Export Function
Robust assays for Gle1 roles in translation initiation and transla-
tion termination have to date been established only in the yeast586 Cell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc.S. cerevisiae model. In addition, due to protein solubility issues,
reconstitution of Gle1-IP6 activation of Dbp5 has only been
possible with the S. cerevisiae proteins. Thus, to further analyze
the potential perturbations of FinMajor function in mRNA export,
we conducted a series of experiments with yGle1. First, to
directly test whether the yGle1 N-terminal region impacts Dbp5
activation, purified recombinant MPB-yGle1 proteins were
assayed for in vitro Dbp5 ATPase stimulation. As reported,
the C-terminal region of yGle1 (residues 241–538; D240Gle1)
with IP6 is sufficient for stimulating Dbp5’s ATPase activity
(Figure S4A; Weirich et al., 2006). In side-by-side assays, the
relative stimulation activity levels for full-length yGle1 and
y-D240Gle1 were similar (Figure S4A). Thus, in vitro activation
Dbp5 did not require a functional yGle1 N-terminal coiled-coil
domain.
Based on the sequence and structural homologies and the fact
that the hGle1 coiled-coil domain can partially complement the
role of the yGle1 domain (Watkins et al., 1998), we designed
FinMajor mimic insertions in yGle1 for tests of in vivo function. In
silico analysis with the Paircoil2 coiled-coil prediction program
showed that insertion of a three amino acid PFQ motif after
amino acid 136 or 149 in yGle1 would potentially disrupt
coiled-coil formation in a manner that would effectively mimic
the structural effects of the PFQ found after residue 144 in the
FinMajor protein (Figure 1C; Tables S1 and S2; Nousiainen
et al., 2008). Importantly, the modeling analysis also predicted
regions of the yGle1 coiled-coil domain that should be impacted
less by a PFQ insertion. For example, adding PFQ after amino
acid 157 in yGle1 was not predicted to change the potential for
the region to form a coiled-coil (Figure 1C; Table S2). Based
on this, y-gle1-136^PFQ, y-gle1-149^PFQ, and y-gle1-157^PFQ
mutants were generated. The mutant strains showed no growth
defects compared to wild-type yGLE1, indicating no global
folding defects for the proteins (Figure 5A). Moreover, purified
recombinant MBP-y-gle1-136^PFQ and MBP-y-gle1-149^PFQ
proteins activated Dbp5 to the same relative level as wild-type
MBP-yGle1 (Figure S4A). In addition, live-cell, direct fluores-
cence microscopy of yeast cells showed that the GFP-tagged
y-gle1^PFQ proteins localized predominantly at the nuclear rim
in a similar manner to wild-type GFP-yGle1 (Figure S5G) and
GFP-FinMajor in HeLa cells (Figure 6B).
Next, synthetic fitness defects were tested for double mutants
generated from the pairwise combination of the respective
y-gle1^PFQ mutants with mRNA export and/or translation
mutants. This included several mRNA-export-specific mutants
(nup100D, nup42D, and rat7-1(nup159)), a translation initiation
mutant (nip1-1), a translation termination mutant (sup45-2), and
two mutants with defects in both mRNA export and translation
termination (rat8-2(dbp5) and ipk1D; Bolger et al., 2008; Murphy
and Wente, 1996; Stutz et al., 1997). The y-gle1-157^PFQmutant
did not have synthetic fitness defects in any of the tested double
mutants (Figures 5B, S4B, and S4C), correlating with the predic-
tion that it would not perturb the coiled-coil region. Strikingly, the
y-gle1-136^PFQ and y-gle1-149^PFQ mutants had no effect when
combined with either nip1-1 or sup45-2. However, the y-gle1-
136^PFQ and y-gle1-149^PFQ mutants were synthetically lethal
when combined with the nup100D or the rat7-1(nup159) mutant
(Figure 5B). The y-gle1-136^PFQwas also synthetically lethal with
Figure 4. FinMajor Has a Defect in Nuclear Poly(A)
+ RNA Export
(A) hGLE1 siRNA treatment depletes endogenous hGle1 protein levels. Immunoblot analysis of hGle1 and actin protein levels in scrambled control (CTRL) or
hGLE1 siRNA-treated HeLa cells transfected with the indicated GFP-tagged proteins.
(B) Nuclear poly(A)+ RNA accumulation in hGLE1 siRNA-treated cells expressing the indicated GFP-tagged proteins, detected by in situ oligo-dT hybridization
and direct fluorescence microscopy. See Figure S3B for quantification of the nucleocytoplasmic distribution of poly(A)+ RNA.nup42D (Figure 5B). This revealed a separation of function with
the y-gle1-136^PFQ and y-gle1-149^PFQ mutants having defects
in mRNA export and not in translation.
In combination with the ipk1D or the rat8-2(dbp5) mutant, only
the y-gle1-136^PFQ allele showed synthetic growth defects
compared to the single mutants (Figures S4B and S4C). Given
that ipk1D double mutants were viable at the permissive growth
temperature and that Ipk1 (for IP6 production) is required for both
mRNA export and translation termination (Bolger et al., 2008),
the y-gle1^PFQ ipk1D mutants were excellent candidates for
assaying functional effects. After shifting to the nonpermissive
growth temperature of 37C, a significant percentage of the
y-gle1-136^PFQ ipk1D and the y-gle1-149^PFQ ipk1D cells
showed nuclear poly(A)+RNA accumulation, whereas the
y-gle1-157^PFQ ipk1D cells did not exhibit a defect (Figures 5C
and S4D). Next, a plasmid-based reporter assay was used to
assess translation termination. By monitoring for production of
tandem b-galactosidase/luciferase proteins that are separated
by either a stop codon, a stem loop, or no stop codon in their
intervening linker, the level of stop codon readthrough was
determined (Stahl et al., 1995). As reported (Bolger et al., 2008;
Alca´zar-Roma´n et al., 2010), the ipk1D single mutant had
25% readthrough. In comparison, no enhanced defects in
termination efficiency were detected for any of the ipk1D
y-gle1^PFQ double mutants (Figure 5D). As an independent test
for translation initiation, we investigated whether expression of
a y-gle1DCC mutant (with an internal in-frame deletion of the
sequence encoding the coiled-coil domain) suppressed the
growth defects linked to translation initiation in the y-gle1-2
nip1-1 mutant (Figure 5E). This was indeed observed. In
contrast, y-gle1DCC expression did not rescue themRNA export
defect in y-gle1-4 cells (Figure 5C). Thus, y-gle1^PFQ mutants
that mimic FinMajor had specific defects in mRNA export that
correlated with the FinMajor results.yGle1 Oligomerization Is Required In Vivo
We previously showed that expression of a chimeric yeast-
humanGle1 protein rescues temperature-sensitive growth prop-
erties of a y-gle1-4 S. cerevisiae mutant (Watkins et al., 1998).
Specifically, when the sequence encoding the essential coiled-
coil domain of yGle1 is deleted (y-gle1DCC), it can be replaced
by an in-frame fragment encoding the coiled-coil domain of
hGle1 (+hGLE1 CC; Figure 5F). We further tested a FinMajor
coiled-coil (+FinMajor CC) chimera, and it rescued growth of the
y-gle1-4 strain at 30C to a similar level as the hGle1-CC
chimera. However, neither the hGle1-CC nor the FinMajor-CC
chimera complemented a lethal y-gle1D mutant. This indicated
that the y-gle1DCC+hGLE1-CC was not fully functional, and in
the context of the chimera, the hGle1-CC domain was potentially
perturbed in a manner similar to FinMajor. Building on this, we
investigated whether swapping in a heterologous oligomeriza-
tion domain would complement functionality in vivo. Expression
of a chimeric protein with the coiled-coil region of yGle1 swap-
ped for that of the well-characterized transcription factor Gcn4
(O’Shea et al., 1991; +GCN4) partially rescued the tempera-
ture-sensitive y-gle1-4 phenotype (Figure 5F), revealing that olig-
omerization is important for yGle1 function in vivo.
Nucleocytoplasmic Shuttling of FinMajor Is Inhibited
Proper hGle1 nucleocytoplasmic shuttling is critical for mRNA
export and requires a unique 39-amino-acid span in the C-termi-
nal region (Figure 1B; Kendirgi et al., 2003). Given that FinMajor
was defective in mRNA export and oligomer structure but still
showed steady-state localization at the nuclear rim (Figure 6B),
we examined GFP-FinMajor dynamics in living cells using fluores-
cence recovery after photobleaching (FRAP). Due to the homo-
zygous recessive FinMajor disease phenotype, experiments
were conducted in HeLa cells with and without hGLE1 siRNA
treatment (as in Figure 3). Nuclei of cells transiently expressingCell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc. 587
Figure 5. The FinMajor Mimic y-gle1
^PFQ
Alleles Have Specific Defects in mRNA
Export
(A) y-gle1^PFQ mutants exhibit no growth defect.
Growth of the indicated strains in 5-fold serial
dilution on YPD was monitored at the tempera-
tures shown.
(B) y-gle1^PFQ mutants display genetic inter-
actions with mRNA export mutants. Strains
bearing the indicatedmutation in combination with
y-gle1D harboring a y-gle1^PFQ-LEU plasmid and
a yGLE1/URA3 plasmid were monitored for
growth at 23C. Failure to grow on synthetic
complete media containing 5-FOA indicates syn-
thetic lethality.
(C) The yGle1 PFQ insertions that mimic FinMajor
perturb mRNA export, and y-gle1DCC expression
does not rescue export defects. Nuclear accu-
mulation of poly(A)+ RNA was detected by in situ
oligo-dT hybridization following a shift to 37C for
2 hr (ipk1D y-gle1D) or 1 hr (y-gle1-4). Calculations
were based on >100 cells/condition. See Fig-
ure S4D for representative fluorescence in situ
hybridization images.
(D) y-gle1^PFQ mutants exhibit no defect in
translation termination. Ratios of luciferase and
b-galactosidase activities were determined and
readthrough efficiency expressed as the percent-
age from the reporter with a stop codon inserted
in-frame into the linker region between the tandem
b-galactosidase and luciferase coding sequences
(denoted the TMV reporter) compared to the re-
porter lacking a stop codon (the TQ control; Stahl
et al., 1995). SEM was calculated from three in-
dependent experiments.
(E) y-gle1DCC rescues the temperature sensitivity
of y-gle1-2 nip1-1. Growth of serially diluted
strains on LEU media was monitored at the
indicated temperatures.
(F) Oligomerization of Gle1 is required for function
in vivo.Mutant y-gle1-4 strains harboring plasmids
expressing yGLE1, vector only, y-gle1DCC,
y-gle1DCC+hGLE1-CC, y-gle1DCC+GCN4, or
y-gle1DCC+FinMajor-CC were monitored for
growth in 5-fold serial dilution on LEU media
at the temperatures shown. (Left) Schematic
representation of the coiled-coil chimeric proteins
with yGle1 (red), Gcn4 (yellow), hGle1 (green), and
FinMajor (green with white bar indicating PFQ
insertion).
See also Figure S4.
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Figure 6. Nucleocytoplasmic Shuttling Dynamics Are Altered for the LCCS1 FinMajor Disease Protein
(A and B) FinMajor has altered nuclear shuttling activity. (A) FRAP analysis of HeLa cells expressing GFP-hGLE1B and GFP-FinMajor. (B) FRAP analysis of hGLE1
siRNA-treated HeLa cells expressing siRNA-resistant GFP-hGLE1BR or GFP-FinMajor
R. The scale bar represents 10 mm.
(C and D) Recovery curves of the experimentally determined bleached region, fit with a one-phase association model. Error bars represent mean ± 95% CI
with nR 12 cells from three independent experiments.
See also Figure S5.a respective GFP-tagged protein were photobleached, and the
nuclear GFP fluorescence was monitored over time (Figures 6
and S5). The FRAP data sets were fit with a one-phase expo-
nential association model. Importantly, the relative half-time
(t1/2) for wild-type GFP-hGle1B nuclear signal after FRAP in
untreated HeLa cells (Figures 6A and 6C) was 12.3 min and
correlated with our previous measurements by fluorescence
loss in photobleaching (Kendirgi et al., 2003). When GFP-
FinMajor was assayed by FRAP in untreated cells, the t1/2 was
not significantly different from wild-type GFP-hGle1B (Figures
6A and 6C). This was expected due to the homozygous reces-
sive nature of the LCCS1 disease pathology (Nousiainen et al.,
2008). FRAP analysis of wild-type GFP-hGle1BR in hGLE1
siRNA-treated cells showed similar shuttling dynamics (t1/2
10.3 min) as compared to the presence of endogenous hGle1
(Figures 6B and 6D). However, strikingly, the shuttling dynamics
of GFP-FinMajor
R were significantly slower (t1/2 20.6 min) in
hGLE1 siRNA-treated cells (Figures 6B and 6D). In sum, as in
the LCCS1 disease state, when expressed as the only hGle1
in the siRNA-treated cells, FinMajor had inhibited nucleocyto-
plasmic shuttling. Thus, the defect in mRNA export was poten-tially due to the altered FinMajor oligomer structural state impact-
ing nucleocytoplasmic shuttling.
hGle1 Requires the Coiled-Coil Domain for NPC
Localization
The hGle1 coiled-coil domain alone is not sufficient for nuclear
rim localization (Kendirgi et al., 2005). To further analyze for roles
of the hGle1 coiled-coil domain in subcellular localization, a
GFP-tagged h-gle1B lacking the coiled-coil domain (GFP-h-
gle1BDCC) was monitored. HeLa cells were cotransfected with
plasmids expressing Pom121-mCherry and either GFP-hGle1B
or a GFP-h-gle1BDCC. As reported, direct fluorescence micro-
scopy in living cells revealed that GFP-hGle1B localized robustly
to the nuclear rim overlapping with mCherry-Pom121 (Fig-
ure S5F; Kendirgi et al., 2003). In contrast, the nuclear rim signal
intensity for GFP-h-gle1BDCC was markedly reduced (Fig-
ure S5F). Immunoblotting showed similar expression levels for
both GFP-tagged proteins (Figure S5E). FRAP analysis revealed
that GFP-h-gle1BDCC shuttled faster than wild-type in both un-
treated (t1/2 8.0 min versus 12.3 min; Figures S5C and 6C) and
hGLE1 siRNA-treated (t1/2 5.0 min versus 10.3 min; FiguresCell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc. 589
S5D and 6D) cells. Overall, the hGle1 oligomeric statemodulated
both NPC localization and nucleocytoplasmic dynamics.
DISCUSSION
In this report, we document a requirement for Gle1 self-associa-
tion during mRNA export and uncover molecular defects
underlying a lethal human disease LCCS1. Our results show
that wild-type Gle1 protomers form discrete multimers and
higher-order disk structures in vitro, with evidence for dimer
formation happening in living cells. This self-association occurs
through the essential Gle1 coiled-coil domain wherein the
LCCS1 FinMajor disease alteration resides. Importantly, disk
structures formed with the FinMajor coiled-coil domain are more
disordered and malformed. Moreover, in HeLa cells, the FinMajor
protein is defective in mRNA export and has slowed nucleocyto-
plasmic shuttling. We propose that LCCS1 disease pathology is
due to perturbations in Gle1 oligomerization and shuttling that
disrupt efficient nuclear export of mRNA at NPCs.
Coiled-coil domains are often utilized to mediate the formation
of biological homo and hetero-oligomeric complexes and
directly impact protein function (Burkhard et al., 2001). We spec-
ulate that the FinMajor is a distinct perturbation of the hGle1
oligomeric structure compared to the h-gle1-DCC that does
not oligomerize. This is based on the different effects on nucleo-
cytoplasmic shuttling and steady-state NPC localization. FinMajor
shuttles slower and is detected at the nuclear rim, contrasted
with h-gle1-DCC which shuttles faster and is not rim localized.
Thus, oligomerization might regulate Gle1 residence time at the
NPC and hGle1 interactions with hNup155 and hCG1 could
potentially facilitate Gle1 self-association. It is striking that the
FinMajor analogous alleles inS. cerevisiae (y-gle1
^PFQ) specifically
disrupt mRNA export function, but not yGle1 roles in translation
initiation or termination, and that expressing y-gle1DCC rescues
translation initiation. Thus, proper Gle1 self-association might
only be strictly required at the NPC.
Our in vitro studies reveal that Gle1 forms large oligomeric disk
structures with an average diameter of 25.8 nm (Figure 2). This
was surprising, and such structures have not been previously re-
ported with other isolated NPC-associated factors. It is tempting
to speculate that these disk structures might be present in the
NPC, which measures 105 nm in total diameter (Maimon
et al., 2012). However, there are no reports of such an NPC-
associated disk-like particle in the published structural studies
of NPCs in intact cells or of isolated NPCs or nuclear envelopes
(Frenkiel-Krispin et al., 2010; Kiseleva et al., 2004; Maimon et al.,
2012; Yang et al., 1998). In intact cells, the electron density of
such a disk might not be detected via tomography approaches.
It is also possible that the Gle1 oligomer dissociates (partially or
fully) during NPC or nuclear envelope isolation. Further studies
are needed to investigate these possibilities and to determine
the stoichiometry within the Gle1 oligomer in vitro and in vivo.
Additionally, the presence of Gle1-binding partners in vivo will
likely play important structural and/or regulatory roles affecting
how Gle1 self-associates. Overall, using FRET microscopy, we
observed hGle1 self-association in living cells (Figures 3A and
3B) and can conclude that, at a minimum, a dimer interaction
exists at the NPC.590 Cell 155, 582–593, October 24, 2013 ª2013 Elsevier Inc.Gle1/IP6 function at the NPC cytoplasmic face triggers Dbp5-
mediated mRNP remodeling and facilitates directional mRNA
export through the NPC (Alca´zar-Roma´n et al., 2006; Tran
et al., 2007; Weirich et al., 2006). As part of the Dbp5 ATPase
cycle, release of ADP from Dbp5 is mediated by Nup159 binding
at the NPC cytoplasmic face (Noble et al., 2011). Interestingly,
Nup159 protomers dimerize by interaction with Dyn2 (Stelter
et al., 2007). Thus, both Dbp5 modulators at the NPC (Gle1 for
ATP loading and ATPase activation and Nup159 for ADP release)
are at least dimers at the NPC.
As the C-terminal yGle1 domain is sufficient in vitro for stimu-
lating Dbp5 ATPase activity, there are at least two working
models by which Gle1 self-association might function in
mRNA export. First, oligomerization might promote Gle1 enrich-
ment at the NPC and generate a self-organized platform of
multiple C-terminal Gle1 domains. This, in turn, could allow
stimulation of the same Dbp5 molecule multiple times, or multi-
ple Dbp5 molecules simultaneously, to promote efficient mRNP
remodeling and directional mRNA export. Preliminary support
for this model can be drawn from the y-gle1DCC+GCN4
chimera complementation results, wherein the Gcn4 coiled-
coil domain facilitates assembly of parallel aligned dimers
(O’Shea et al., 1991).
Alternatively, self-association might allow multiple distinct in-
teractions with individual protomers in a Gle1 oligomer. Based
on structural analysis of the yGle1 C-terminal domain (Montpetit
et al., 2011), it is possible that the binding interfaces for Dbp5 and
Nup42 are mutually exclusive. Thus, Gle1 self-association would
allow a dimer (or higher order oligomers) to coincidentally bind
the NPC and activate Dbp5 for mRNA export. Our ongoing
studies will be aimed at investigating the Nup- and Dbp5-binding
interfaces on the oligomeric complex.
This work implicates Gle1 dysregulation of Dbp5’s mRNP
remodeling activity during mRNA export as the key molecular
pathological event in LCCS1. As the RNA-binding protein
composition of an mRNP dictates both its regulation and func-
tion during gene expression (Mu¨ller-McNicoll and Neugebauer,
2013), altered mRNP remodeling during mRNA export likely
has global cellular impacts. In addition to LCCS1, human genetic
linkage analysis has identified additional GLE1 causal mutations
that result in the lethal arthrogryposis with anterior horn cell dis-
ease (Nousiainen et al., 2008). Further, recent deep sequencing
studies report gle1 mutant alleles in other human diseases (Al-
Qattan et al., 2012; Tzschach et al., 2012). For these diseases,
it is unclear whether or how hGle1 has cell-type-specific effects.
Indeed, our studies of GLE1 depletion in zebrafish show poten-
tial impacts on multiple proliferative organ precursors (Jao
et al., 2012). With Gle1 uniquely positioned to modulate mRNP
composition through regulation of multiple DBPs (Alca´zar-
Roma´n et al., 2006; Bolger and Wente, 2011; Weirich et al.,
2006), we speculate that disruption of specific Gle1 mechanistic
steps in export and/or translation results in different pathological
outcomes.
Defective oligomerization of the SMN protein has been caus-
ally linked to some cases of spinal muscular atrophy (Lorson
et al., 1998; Pellizzoni et al., 1999). In this case, defects in
SMN oligomerization cause ineffective assembly of the small
nuclear RNPs and disruption of pre-mRNA splicing (Shpargel
and Matera, 2005; Wan et al., 2005). Our analysis of Gle1
self-association extends this paradigm for perturbations of
RNP effector oligomerization and highlights altered mRNP re-
modeling as a molecular disease mechanism. Taken together,
this work provides evidence for the cellular mechanism underly-
ing the lethal human LCCS1 disease and impacts the broader
understanding of the involvement of defective NPCs, altered
mRNA transport, and misregulated gene expression in human
disease.
EXPERIMENTAL PROCEDURES
Full details of the experimental procedures can be found in the Extended
Experimental Procedures.
HeLa Cell Culture and Immunoblotting
HeLa cells were cultured in complete medium (DMEM; Gibco) supplemented
with 10% fetal bovine serum (FBS) (Atlanta Biologicals) at 37C in 5% CO2.
Transient transfections of GFP expression vectors were performed using
Fugene 6 (Promega) according to manufacturer’s instructions. For siRNA
experiments, cells were first transfected with a scrambled siRNA or siRNA-
targeting hGLE1 using HiPerFect (QIAGEN). For live-cell-imaging experiments,
cells were plated in 35 mm No. 1.5 glass bottom dishes (MatTek). Before
imaging, culture medium was replaced with phenol red-free DMEM (Gibco)
supplemented with 10% FBS and 25 mM HEPES. For paraformaldehyde
fixation, cells were plated on No. 1.5 round coverslips in a 24-well plate
(Fisher Scientific). For immunoblots, HeLa cells were processed as described
(Bolger et al., 2008). Protein bands were visualized with a Li-COR Odyssey
scanner.
Yeast Strains, Plasmids, and Two-Hybrid Analysis
Tables S3 and S4 list the plasmids and S. cerevisiae strains used in this study.
Yeast strains were grown at indicated temperatures in either YPD (2%
peptone, 2% dextrose, 1% yeast extract) or selective minimal media lacking
appropriate amino acids and supplemented with 2% dextrose and 5-fluoroor-
otic acid (5-FOA; United States Biological) as needed at 1.0 mg/ml. Yeast two-
hybrid analysis was performed as described (Clontech Laboratories; Protocol
No. PT3024-1), with activities reported normalized to GBD-hGle1B b-galacto-
sidase levels.
In Situ Hybridization
S. cerevisiae cells were processed as described (Wente and Blobel, 1993).
To localize poly(A)+RNA in HeLa cells, cells were fixed 72 hr post-siRNA
treatment and processed as described (Watkins et al., 1998). Both human
and yeast cells were incubated with Cy3-conjugated oligo d(T) in hybridiza-
tion buffer for 2 hr. Images were acquired using a microscope (BX50;
Olympus), Olympus 1003/1.3 UPlanF1 objective (yeast samples) or Olympus
403/1.3 UPlanF1 objective (HeLa samples), and digital charge-coupled
device camera (Orca-R2; Hamamatsu). Images were processed with ImageJ
(National Institutes of Health [NIH]) or Adobe Photoshop CS6.
Translation Termination
Translation termination experiments using the tandem b-galactosidase-lucif-
erase reporters were performed as described (Alca´zar-Roma´n et al., 2010;
Bolger et al., 2008).
Biochemical Analysis of Recombinant Proteins
MBP-TEV-yGle1(241–528), MBP-TEV-yGle1, MBP-TEV-y-gle1-136^PFQ,
MBP-TEV-y-gle1-149^PFQ, and GST-Dbp5 were purified as described (Tran
et al., 2007). The GST-hGle1(1–362), MBP-hGle1(1–362), and MBP-h-gle1(1–
365)-FinMajor were expressed in E. coli BL21-RIL (DE3) cells (Stratagene).
Bacteria were lysed by sonication in buffer (200 mM NaCl, 20 mM Tris,
pH 7.5), and the soluble fraction was used for affinity chromatography with
either amylose resin (New England Biolabs) or glutathione-coupled Sepharose
(GE Healthcare) according to manufacturer recommendations. Size exclusionchromatography with a S200 column (GE Healthcare) was used to further
isolate complexes. Pyruvate kinase/lactate dehydrogenase-coupled ATPase
assays (Noble et al., 2011), soluble binding assays (Kendirgi et al., 2005),
and SVAU analysis (Roberts-Galbraith et al., 2010) were performed as
described. Velocity scans were analyzed using Sedfit (version 14.0; Schuck
and Rossmanith, 2000). Size distributions were determined for a confidence
level of p = 0.95, a resolution of n = 200, and sedimentation coefficients
between 0 and 80 S.
Live-Cell Microscopy
All images were processed with ImageJ (NIH) or Adobe Photoshop CS6.
Wild-type S. cerevisiae (W303) with plasmids harboring either y-GLE1-GFP
(pBRR118b) or y-gle1-136^PFQ-GFP (pSW3779) were imaged as described
(Noble et al., 2011) using a microscope (BX50; Olympus), Olympus 1003/1.3
UPlanF1 oil immersion objective, and digital charge-coupled device camera
(Orca-R2; Hamamatsu). For HeLa cells, photoacceptor bleaching and
sensitized emission FRET microscopy experiments were conducted on a
confocal microscope (LSM710; Zeiss) using a Zeiss 403/1.1 C-Apochromat
water objective. Photoacceptor bleaching was performed on HeLa cells co-
transfected with (1) pSW3775 (Cer-hGLE1B) and pSW3774 (Venus-hGLE1B),
(2) mCerulean3-C1 and pSW3774, or (3) pSW3977 (Venus-hGle1B(362698))
and pSW3775. Cell volume was bleached by exciting at 514 nm throughout
the targeted region, and FRET efficiency was calculated. For sensitized
emission FRET measurements, HeLa cells were cotransfected with either
pSW3775 and pSW3774 or mCerulean3 and pSW3774. A NFRET signal for
indicated regions was determined using standard methods. FRAP was
performed on untreated HeLa cells cotransfected with Pom121-mCherry
and either GFP-hGLE1B (pSW1831), GFP-FinMajor (pSW3903), or GFP-h-
gle1BDCC (pSW3976) or on hGLE1 siRNA-treated HeLa cells cotransfected
with Pom121-mCherry and either siRNA-resistant GFP-hGLE1BR (pSW3908),
GFP-FinMajor
R (pSW3945), or GFP-h-gle1BDCC (pSW3976). All FRAP micro-
scopyexperimentswere conductedonaconfocalmicroscope (LSM710;Zeiss)
using a Zeiss 403/1.1 C-Apochromat water objective configured for time-
lapse acquisition. Bleaching was achieved by exciting at 488 nm throughout
the targeted region.
Electron Microscopy
Uranyl-formate-stained sampleswere prepared as described (Ohi et al., 2004).
Samples were imaged on a FEI Morgagni electron microscope operated at
an acceleration voltage of 100 kV. Images were recorded at a magnification
of 22–36,0003 and collected using a 1K 3 1K charge-coupled device (CCD)
camera (ATM). To prepare samples in vitrified ice, a holey carbon grid
(Quantifoil Micro Tools) was glow-discharged and used to adsorb gel-filtra-
tion-purified human Gle1 particles. Grids were blotted and frozen in liquid
ethane using a Vitrobot (FEI). Vitrified specimens were imaged under low-
dose conditions at a nominal magnification of 100,0003 at defocus values
ranging from 3 to 5 mm using a Gatan cryotransfer holder in a FEI Tecnai
200 kV electron microscope equipped with a field emission electron source
(FEI) and 4K 3 4K Gatan Ultrascan CCD.
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